iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells

Proteomics

Volumn 14, Issue 1, 2014, Pages 51-73

  Chen, Hao ^a   Xu, Lina ^a   Yin, Lianhong ^a   Xu, Youwei ^a   Han, Xu ^a   Qi, Yan ^a   Zhao, Yanyan ^a   Liu, Kexin ^a   Peng, Jinyong ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Biomedicine; Colorectal cancer; Cytotoxicity; Dioscin

Indexed keywords

DIOSCIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN HCT116; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NICK END LABELING; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

APOPTOSIS; BIOMEDICINE; COLORECTAL CANCER; CYTOTOXICITY; DIOSCIN;

APOPTOSIS; CELL CYCLE; CELL SHAPE; CELL SURVIVAL; COLONIC NEOPLASMS; DIOSGENIN; DNA DAMAGE; HCT116 CELLS; HUMANS; ISOTOPE LABELING; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTEINS; PROTEOME; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 84892422840     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201300101     Document Type: Article

References (74)

1. Haggar, F. A., Boushey, R. P., Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin. Colon Rectal. Surg. 2009, 22, 191-197.
2. Cunningham, D., Atkin, W., Lenz, H. J., Lynch, H. T. et al., Colorectal cancer. Lancet 2010, 375, 1030-1047.
3. Alberts, S. R., Wagman, L. D., Chemotherapy for colorectal cancer liver metastases. Oncologist 2008, 13, 1063-1073.
4. Lévi, F., Zidani, R., Misset, J. L., Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International organization for cancer chronotherapy. Lancet 1997, 350, 681-686.
5. Akiko, S., Mieko, O., Akiko, M., Hideji, Y. et al., Identification of phosphorylated serine-15 and -82 residues of HSPB1 in 5-fluorouracil- resistant colorectal cancer cells by proteomics. J. Proteomics 2012, 75, 806-818.
6. Schüller, J., Cassidy, J., Dumont, E., Roos, B. et al., Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother. Pharmacol. 2000, 45, 291-297.
7. Xu, J. D., Yang, Y., Traditional Chinese medicine in the Chinese health care system. Health Policy 2009, 90, 133-139.
8. Wang, S. P., Wu, X., Tan, M., Gong, J. et al., Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy. J. Ethnopharmacol. 2012, 14, 33-45.
9. Jonas, W. B., Alternative medicine-learning from the past, examining the present, advancing to the future. J. Am. Med. Assoc. 1998, 280, 1616-1618.
10. Hong, M. Y., Seeram, N. P., Zhang, Y., Heber, D., Anticancer effect of Chinese red yeast rice versus monacolin K alone on colon cancer cells. J. Nutri. Biochem. 2008, 19, 448-458.
11. Tan, K. Y., Liu, C. B., Chen, A. H., Ding, Y. J. et al., The role of traditional Chinese medicine in colorectal cancer treatment. Tech. Coloproctol. 2008, 12, 1-6.
12. Adewale, M. A., (-)-trans-β-Elemene and related compounds: occurrence, synthesis, and anticancer activity. Tetrahedron 2009, 65, 5145-5159.
13. Chidambara Murthy, K. N., Jayaprakasha, G. K., Patil, B. S., The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur. J. Pharmacol. 2012, 688, 14-21.
14. Hong, J., Smith, T. J., Ho, C. T., August, D. A. et al., Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachid -onic acid in human colon mucosa and colon tumor tissues. Biochem. Pharmacol. 2001, 62, 1175-1183.
15. Liu, C. Z., Zhou, H. Y., Yan, Q., Fingerprint analysis of Dioscorea nipponica by high- performance liquid chromatography with evaporative light scattering detection. Anal. Chim. Acta. 2007, 582, 61-68.
16. Li, H., Huang, W., Wen, Y. Q., Gong, G. H. et al., Anti-thrombotic activity and chemical characterization of steroidal saponins from Dioscorea zingiberensis C. H. Wright. Fitoterapia 2010, 81, 1147-1156.
17. Wang, G. X., Han, J., Zhao, L. W., Jiang, D. X. et al., Anthelmintic activity of steroidal saponins from Paris polyphylla. Phytomedicine 2010, 17, 1102-1105.
18. Cho, J. Y., Choi, H. M., Lee, J. Y., Kim, M. S. et al., The antifungal activity and membrane -disruptive action of dioscin extracted from Dioscorea nipponica. Biochim. Biophys. Acta. 2013, 1828, 1153-1158.
19. Zhao, X. M., Cong, X. N., Zheng, L. L., Xu, L. N. et al., Dioscin, a natural steroid saponin, shows remarkable protective effect against acetamino -phen-induced liver damage in vitro and in vivo. Toxicol. Lett. 2012, 214, 69-80.
20. Lu, B. N., Xu, Y. S., Xu, L. N., Cong, X. N. et al., Mechanism investigation of dioscin against CCl4-induced acute liver damage in mice. Environ. Toxicol. Pharmacol. 2012, 34, 127-135.
21. Liu, C. H., Wang, Y., Wu, C. C., Pei, R. J. et al., Dioscin's antiviral effect in vitro. Virus Res. 2012, 172, 9-14.
22. Wang, Y., Che, C. M., Chiu, J. F., He, Q. Y., Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic- based study. J. Proteome Res. 2007, 6, 4703-4710.
23. Cai, J., Liu, M., Wang, Z., Ju, Y., Apoptosis induced by dioscin in Hela cells. Biol. Pharm. Bull. 2002, 25, 193-196.
24. Hu, M. M., Xu, L. N., Yin, L. H., Qi, Y. et al., Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J. Appl. Toxicol. 2013, 33, 712-722.
25. 2±-mediated mitochondrion pathway. Asian Pac. J. Cancer Prev. 2011, 12, 1361-1366.
26. Wang, Z., Cheng, Y., Wang, N., Wang, D. M. et al., Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol. Ther. 2012, 13, 138-147.
27. Lv, L., Zheng, L., Dong, D., Xu, L. et al., Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactiveoxygen species: a potential new drug for treatment of glioblastoma multiforme. Food Chem. Toxicol. 2013, 59, 657-669.
28. Sun, B. T., Zheng, L. H., Bao, Y. L., Yu, C. L. et al., Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells. Eur. J. Pharmacol. 2011, 654, 129-134.
29. Blackstock, W. P., Weir, M. P., Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999, 17, 121-127.
30. Gupta, N., Benhamida, J., Bhargava, V., Goodman, D. et al., Comparative proteogen -omics: combining mass spectrometry and comparative genomics to analyze multiple genomes. Genome Res. 2008, 18, 1133-1142.
31. Dix, M. M., Simon, G. M., Cravatt, B. F., Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell 2008, 134, 679-691.
32. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
33. Rukmangadachar, L. A., Kataria, J., Hariprasad, G., Samantaray, J. C. et al., Two- dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin. Proteomics 2011, 8, 4-16.
34. Feng, H., Li, X., Niu, D., Chen, W. N., Protein profile in HBx transfected cells: a comparative iTRAQ-coupled 2D LC-MS/MS analysis. J. Proteomics 2010, 73, 1421-1432.
35. Wang, Y., Cheung, Y. H., Yang, Z., Chiu, J. F. et al., Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics 2006, 6, 2422-2432.
36. Poulsen, J. W., Madsen, C. T., Young, C., Kelstrup, C. D. et al., Comprehensive profiling of proteome changes upon sequential deletion of deubiquitylatingenzymes. J. Proteomics 2012, 75, 3886-3897.
37. Parent, N., Winstall, E., Beauchemin, M., Paguet, C. et al., Proteomic analysis of enriched lysosomes at early phase of camptothecin- induced apoptosis in human U-937 cells. J. Proteomics 2009, 72, 960-973.
38. Kolla, V., Jenö, P., Moes, S., Lapaire, O. et al., Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples inpregnancies at risk for preeclampsia. J. Biomed. Biotechnol. 2012, 2012, 305964.
39. Hogeweg, P., The roots of bioinformatics in theoretical biology. PLoS Comput. Biol. 2011, 7, e1002021.
40. Kanehisa, M., Goto, S., KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27-30.
41. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification for biology. Nat. Genet. 2000, 25, 25-29.
42. Yin, L. H., Xu, Y. W., Qi, Y., Han, X. et al., A green and efficient protocol for industrial-scale preparation of dioscin from Dioscorea nipponica Makino by two-step macroporous resin column chromatography. Chem. Eng. J. 2010, 165, 281-289.
43. Al-Belooshi, T., John, A., Tariq, S., Al-Otaiba, A. et al., Increased mitochon -drial stress and modulation of mitochondrial respiratory enzyme activities in acetaminophen -induced toxicity in mouse macrophage cells. Food Chem. Toxicol. 2010, 48, 2624-2632.
44. Aranda, B., Achuthan, P., Alam-Faruque, Y., Armean, I. et al., The IntAct molecular interaction database in 2010. Nucleic Acids Res. 2010, 38, D525-D531.
45. Prasad, T. S. K., Goel, R., Kandasamy, K., Keerthikumar, S. et al., Human protein reference database-2009 update. Nucleic Acids Res. 2009, 37, D767-D772.
46. Giles, R. H., van Es, J. H., Clevers, H., Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 2003, 1653, 1-24.
47. Dey, A., Lane, D. P., Verma, C. S. Modulating the p53 pathway. Semin. Cancer Biol. 2010, 20, 3-9.
48. Parkash, J., Asotra, K., Calcium wave signaling in cancer cells. Life Sci. 2010, 87, 587-595.
49. Gao, L. L., Li, F. R., Jiao, P., Apoptosis of human ovarian cancer cells induced by Paris chinensis dioscin via a Ca(2+)-mediated mitochondrion pathway. Asian Pac. J. Cancer Prev. 2011, 12, 1361-1366.
50. Wei, Y. D., Xu, Y. S., Han, X., Anti-cancer effects of dioscin on three kinds of human lung cancer cell lines through inducing DNA damage and activating mitochondrial signal pathway. Food Chem Toxicol. 2013, 59, 118-128.
51. Schwartz, M. K., Enzymes used in predicting high risk to colon cancer. Clin. Biochem. 1990, 23, 395-398.
52. Espinoza, A. M., Venook, A. P., Lactic acidosis and colon cancer: oncologic emergency? Clin. Colorectal Cancer 2011, 10, 194-197.
53. Pe'er, D., Hacohen, N., Principles and strategies for developing Network models in cancer. Cell 2011, 144, 864-873.
54. Fu, L. L., Zhou, C. C., Yao, S., Yu, J. Y. et al., Plant lectins: targeting programmed cell death pathways as antitumor agents. Int. J. Biochem. Cell Biol. 2011, 43, 1442-1449.
55. Lee, M. J., Ye, A. S., Gardino, A. K., Heijink, A. M. et al., Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks. Cell 2012, 149, 780-794.
56. Sánchez-Aragó, M., Chamorro, M., Cuezva, J. M., Selection of cancer cells with repressed mitochondria triggers colon cancer progression. Carcinogenesis 2010, 31, 567-576.
57. Ralph, S. J., Rodriguez-Enríquez, S., Neuzil, J., Moreno-Sánchez, R., Bioenerge- tics pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol. Aspects Med. 2010, 31, 29-59.
58. Segditsas, S., Tomlinson, I., Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 2006, 25, 7531-7537.
59. Florea, A. M., Büsselberg, D., Anti-cancer drugs interfere with intracellular calcium signaling. NeuroToxicology 2009, 30, 803-810.
60. Mitchell, P., Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol. Rev. Camb. Philos. Soc. 1966, 41, 445-502.
61. Fulda, S., Galluzzi, L., Kroemer, G., Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov. 2010, 9, 447-464.
62. Wang, J., Yi, J., Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol. Ther. 2008, 7, 1875-1884.
63. Tripathi, M., Singh, B. K., Raisuddin, S., Kakkar, P., Abrogation of nimesulide induced oxidative stress and mitochondria mediated apoptosis by Fumaria parviflora Lam. extract. J. Ethnopharmacol. 2011, 136, 94-102.
64. Renschler, M. F., The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer 2004, 40, 1934-1940.
65. Wang, X., Mandal, A. K., Saito, H., Pulliam, J. F., Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β- catenin signaling pathway. Toxicol. Appl. Pharmacol. 2012, 262, 11-21.
66. Jingushi, K., Takahashi-Yanaga, F., Yoshihara, T., Shiraishi, F., DIF-1 inhibits the Wnt/b- catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines. Biochem. Pharmacol. 2012, 83, 47-56.
67. Ratcliffe, M. J., Itoh, K., Sokol, S. Y., A positive role for the PP2A catalytic subunit in Wnt signal transduction. J. Biol. Chem. 2000, 275, 35680-35683.
68. Seldin, D. C., Landesman-Bollag, E., Farago, M., Currier, N. et al., CK2 as a positive regulator of Wnt signalling and tumourigenesis. Mol. Cell. Biochem. 2005, 274, 63-67.
69. Kim, G. H., Han, J. K., JNK and ROK function in the noncanonical Wnt/RhoA signaling pathway to regulate xenopus convergent extension movements. Dev. Dyn. 2005, 232, 958-968.
70. Prives, C., Hall, P. A., The p53 pathway. J. Pathol. 1999, 187, 112-126.
71. Nantajit, D., Fan, M., Duru, N., Wen, Y. et al., Cyclin B1/Cdk1 phosphorylation of mitochondrial p53 induces anti-apoptotic response. PLoS ONE 2010, 5, e12341.
72. Chatterjee, S., Kundu, S., Sengupta, S., Bhattacharyya, A., Divergence to apoptosis from ROS induced cell cycle arrest: effect of cadmium. Mutat. Res. 2009, 663, 22-31.
73. 2+ transport. Nat. Rev. Cancer 2007, 7, 519-530.
74. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8, 361-375.